Close Menu

NEW YORK ─ GenMark Diagnostics on Monday announced preliminary fourth quarter revenue growth of 84 percent year over year.

For the quarter ended Dec. 31, 2020, the Carlsbad, California-based company expects to report revenues of $50 million, compared to $27.2 million in Q4 2019, which would beat analysts' average estimate of $45.9 million.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.